{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:46:19Z","timestamp":1775976379493,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00292-024-01344-3","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T11:07:15Z","timestamp":1723028835000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesothelioma: molecular pathology and biomarkers","Mesotheliom: Molekularpathologie und Biomarker"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-1591","authenticated-orcid":false,"given":"Yin P.","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/modpathol.2016.181","volume":"30","author":"VJ Amatya","year":"2017","unstructured":"Amatya\u00a0VJ, Kushitani\u00a0K, Mawas\u00a0AS et\u00a0al (2017) MUC4, a\u00a0novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30:672\u2013681","journal-title":"Mod Pathol"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","volume":"41","author":"KB Berg","year":"2017","unstructured":"Berg\u00a0KB, Churg\u00a0A (2017) GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol 41:1221\u20131225","journal-title":"Am J Surg Pathol"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno\u00a0R, Stawiski\u00a0EW, Goldstein\u00a0LD et\u00a0al (2016) Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet 48:407\u2013416","journal-title":"Nat Genet"},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone\u00a0M, Harbour\u00a0JW, Brugarolas\u00a0J et\u00a0al (2020) Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov 10:1103\u20131120","journal-title":"Cancer Discov"},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/his.14324","volume":"78","author":"DB Chapel","year":"2021","unstructured":"Chapel\u00a0DB, Dubuc\u00a0AM, Hornick\u00a0JL et\u00a0al (2021) Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma. Histopathology 78:1032\u20131042","journal-title":"Histopathology"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41379-022-01081-z","volume":"35","author":"DB Chapel","year":"2022","unstructured":"Chapel\u00a0DB, Hornick\u00a0JL, Barlow\u00a0J et\u00a0al (2022) Clinical and molecular validation of BAP1, MTAP, P53, and merlin immunohistochemistry in diagnosis of pleural mesothelioma. Mod Pathol 35:1383\u20131397","journal-title":"Mod Pathol"},{"key":"1344_CR7","first-page":"14","volume":"1","author":"LR Chirieac","year":"2011","unstructured":"Chirieac\u00a0LR, Pinkus\u00a0GS, Pinkus\u00a0JL et\u00a0al (2011) The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura. Am J Cancer Res 1:14\u201324","journal-title":"Am J Cancer Res"},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","volume":"44","author":"A Churg","year":"2020","unstructured":"Churg\u00a0A, Naso\u00a0JR (2020) The separation of benign and malignant mesothelial proliferations: New markers and how to use them. Am J Surg Pathol 44:e100\u2013e112","journal-title":"Am J Surg Pathol"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"e2100422","DOI":"10.1200\/PO.21.00422","volume":"6","author":"I Dagogo-Jack","year":"2022","unstructured":"Dagogo-Jack\u00a0I, Madison\u00a0RW, Lennerz\u00a0JK et\u00a0al (2022) Molecular characterization of mesothelioma: Impact of histologic type and site of origin on molecular landscape. JCO Precis Oncol 6:e2100422","journal-title":"JCO Precis Oncol"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/j.modpat.2023.100420","volume":"37","author":"CA Febres-Aldana","year":"2024","unstructured":"Febres-Aldana\u00a0CA, Chang\u00a0JC, Jungbluth\u00a0AA et\u00a0al (2024) Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma. Mod Pathol 37:100420","journal-title":"Mod Pathol"},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","volume":"75","author":"G Guo","year":"2015","unstructured":"Guo\u00a0G, Chmielecki\u00a0J, Goparaju\u00a0C et\u00a0al (2015) Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res 75:264\u2013269","journal-title":"Cancer Res"},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"8","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak\u00a0J, Sanchez-Vega\u00a0F, Hoadley\u00a0KA et\u00a0al (2018) Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov 8:1548\u20131565","journal-title":"Cancer Discov"},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley\u00a0KA, Yau\u00a0C, Hinoue\u00a0T et\u00a0al (2018) Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33\u00a0types of cancer. Cell 173:291\u2013304 e296","journal-title":"Cell"},{"key":"1344_CR14","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2023-0213-RA","author":"YP Hung","year":"2024","unstructured":"Hung\u00a0YP, Chirieac\u00a0LR (2024) Molecular and immunohistochemical testing in mesothelioma and other mesothelial lesions. Arch Pathol Lab Med. https:\/\/doi.org\/10.5858\/arpa.2023-0213-RA","journal-title":"Arch Pathol Lab Med"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","volume":"4","author":"YP Hung","year":"2018","unstructured":"Hung\u00a0YP, Dong\u00a0F, Watkins\u00a0JC et\u00a0al (2018) Identification of ALK rearrangements in malignant peritoneal mesothelioma. JAMA Oncol 4:235\u2013238","journal-title":"JAMA Oncol"},{"key":"1344_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain\u00a0AN, Colby\u00a0TV, Ordonez\u00a0NG et\u00a0al (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 142:89\u2013108","journal-title":"Arch Pathol Lab Med"},{"key":"1344_CR17","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.modpat.2022.100030","volume":"36","author":"Y Li","year":"2023","unstructured":"Li\u00a0Y, Yang\u00a0SR, Chen\u00a0YB et\u00a0al (2023) Neurofibromatosis Type\u00a02-Yes-associated protein and transcriptional coactivator with PDZ-binding motif dual immunohistochemistry is a\u00a0reliable marker for the detection of neurofibromatosis type\u00a02 alterations in diffuse pleural mesothelioma. Mod Pathol 36:100030","journal-title":"Mod Pathol"},{"key":"1344_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41588-023-01321-1","volume":"55","author":"L Mangiante","year":"2023","unstructured":"Mangiante\u00a0L, Alcala\u00a0N, Sexton-Oates\u00a0A et\u00a0al (2023) Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet 55:607\u2013618","journal-title":"Nat Genet"},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","volume":"67","author":"AM Marchevsky","year":"2017","unstructured":"Marchevsky\u00a0AM, Lestang\u00a0N, Hiroshima\u00a0K et\u00a0al (2017) The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the international mesothelioma panel and the MESOPATH national reference center. Hum Pathol 67:160\u2013168","journal-title":"Hum Pathol"},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.modpat.2022.100036","volume":"36","author":"SD Martin","year":"2023","unstructured":"Martin\u00a0SD, Cheung\u00a0S, Churg\u00a0A (2023) Immunohistochemical demonstration of Merlin\/NF2 loss in mesothelioma. Mod Pathol 36:100036","journal-title":"Mod Pathol"},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/PAS.0000000000001469","volume":"44","author":"JR Naso","year":"2020","unstructured":"Naso\u00a0JR, Tsuji\u00a0S, Churg\u00a0A (2020) HEG1 is a\u00a0highly specific and sensitive marker of epithelioid malignant mesothelioma. Am J Surg Pathol 44:1143\u20131148","journal-title":"Am J Surg Pathol"},{"key":"1344_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/modpathol.3800544","volume":"19","author":"NG Ordonez","year":"2006","unstructured":"Ordonez\u00a0NG (2006) The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a\u00a0comparative study. Mod Pathol 19:417\u2013428","journal-title":"Mod Pathol"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.humpath.2016.10.005","volume":"60","author":"D Owen","year":"2017","unstructured":"Owen\u00a0D, Sheffield\u00a0BS, Ionescu\u00a0D et\u00a0al (2017) Loss of BRCA\u00a01-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer. Hum Pathol 60:82\u201385","journal-title":"Hum Pathol"},{"key":"1344_CR24","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","volume":"36","author":"V Panou","year":"2018","unstructured":"Panou\u00a0V, Gadiraju\u00a0M, Wolin\u00a0A et\u00a0al (2018) Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J\u00a0Clin Oncol 36:2863\u20132871","journal-title":"J Clin Oncol"},{"key":"1344_CR25","first-page":"204","volume-title":"WHO Classification of Tumours Thoracic Tumours","author":"JL Sauter","year":"2021","unstructured":"Sauter\u00a0JL, Bueno\u00a0R, Dacic\u00a0S et\u00a0al (2021) Diffuse pleural mesothelioma. In: WHO Classification of Tumours Editorial (ed) WHO Classification of Tumours Thoracic Tumours. IARC Press, Lyon, pp\u00a0204\u2013219"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41698-024-00518-9","volume":"8","author":"M Tagliamento","year":"2024","unstructured":"Tagliamento\u00a0M, Morfouace\u00a0M, Loizides\u00a0C et\u00a0al (2024) EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers. NPJ Precis Oncol 8:37","journal-title":"NPJ Precis Oncol"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5858\/arpa.2019-0647-OA","volume":"145","author":"S Terra","year":"2021","unstructured":"Terra\u00a0S, Roden\u00a0AC, Aubry\u00a0MC et\u00a0al (2021) Utility of immunohistochemistry for MUC4 and GATA3 to aid in the distinction of pleural sarcomatoid mesothelioma from pulmonary sarcomatoid carcinoma. Arch Pathol Lab Med 145:208\u2013213","journal-title":"Arch Pathol Lab Med"},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa\u00a0JR, Cheung\u00a0M, Pei\u00a0J et\u00a0al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022\u20131025","journal-title":"Nat Genet"},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/PAS.0000000000001840","volume":"46","author":"H Yang","year":"2022","unstructured":"Yang\u00a0H, Cheung\u00a0S, Churg\u00a0A (2022) UHRF1 immunohistochemical staining separates benign reactive spindle cell mesothelial proliferations from sarcomatoid mesotheliomas. Am J Surg Pathol 46:840\u2013845","journal-title":"Am J Surg Pathol"},{"key":"1344_CR30","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41467-021-21798-w","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang\u00a0M, Luo\u00a0JL, Sun\u00a0Q et\u00a0al (2021) Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment. Nat Commun 12:1751","journal-title":"Nat Commun"}],"container-title":["Die Pathologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-024-01344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-024-01344-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-024-01344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T21:21:37Z","timestamp":1724448097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-024-01344-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s00292-024-01344-3","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"5 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.P.\u00a0Hung received royalties from Elsevier for authoring chapters in pathology textbooks and an honorarium from the American Society of Clinical Pathology for participating in a continuing medical education (CME) event.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}